The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Nelson Sonja since 2018.
This trader's CIK number is 1674905.
At the time of last reporting, Nelson Sonja was the Chief Financial Officer of Ambrx Biopharma, Inc.. (stock ticker symbol AMAM).
Also see all insider trading activities at Ambrx Biopharma, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2023 | AMAM | 0 | $0 | 12,778 | $125,479 | 0 | $0 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2021 | NK | 0 | $0 | 55,635 | $780,409 | 34,093 | $104,665 |
| 2020 | NK | 0 | $0 | 0 | $0 | 25,000 | $0 |
| 2019 | NK | 0 | $0 | 0 | $0 | 10,000 | $0 |
| 2018 | NK | 0 | $0 | 0 | $0 | 15,000 | $0 |
1. Ambrx Biopharma, Inc. (AMAM)
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2023-10-27 | AMAM | Sale | 12,778 | 9.82 | 125,479 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2021-01-12 | NK | Sale | 16,364 | 15.00 | 245,460 |
| 2021-01-12 | NK | Option Ex | 11,364 | 3.07 | 34,887 |
| 2021-01-04 | NK | Sale | 39,271 | 13.62 | 534,949 |
| 2021-01-04 | NK | Option Ex | 22,729 | 3.07 | 69,778 |
| 2020-08-02 | NK | Option Ex | 10,000 | .00 | 0 |
| 2020-03-23 | NK | Option Ex | 15,000 | .00 | 0 |
| 2019-08-02 | NK | Option Ex | 10,000 | .00 | 0 |
| 2018-03-23 | NK | Option Ex | 15,000 | .00 | 0 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Nelson Sonja (Chief Financial Officer of Ambrx Biopharma, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.